Seeing Is Believing

Currently out of the existing stock ratings of Michael Yee, 288 are a BUY (79.12%), 75 are a HOLD (20.6%), 1 are a SELL (0.27%).
Analyst Michael Yee, currently employed at UBS, carries an average stock price target met ratio of 55.71% that have a potential upside of 38.52% achieved within 196 days. Previously, Michael Yee worked at JEFFERIES.
Michael Yee’s has documented 711 price targets and ratings displayed on 42 stocks. The coverage is on Healthcare, Industrials, Pharmaceuticals sectors.
Most recent stock forecast was given on ALXO, Alx Oncology Holdings at 06-Mar-2026.
Analyst best performing recommendations are on IMRX (IMMUNEERING CORP).
The best stock recommendation documented was for KOD (KODIAK SCIENCES) at 7/24/2023. The price target of $3 was fulfilled within 3 days with a profit of $0.95 (24.05%) receiving and performance score of 80.17.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$200
$198.8 (16566.67%)
$3960
4 years 8 months 24 days ago
(17-Jun-2021)
0/4 (0%)
$103 (106.19%)
Buy
$100
$98.8 (8233.33%)
$3600
5 years 2 months ago
(13-Jan-2021)
2/4 (50%)
$-22.4 (-18.30%)
139
Hold
$120
$118.8 (9900.00%)
$2280
5 years 10 months 7 days ago
(06-May-2020)
5/5 (100%)
$16.79 (16.27%)
44
Hold
$120
$118.8 (9900.00%)
$3000
5 years 10 months 7 days ago
(06-May-2020)
6/6 (100%)
$16.79 (16.27%)
45
Sell
$120
$118.8 (9900.00%)
$1200
6 years 4 months 20 days ago
(21-Oct-2019)
7/7 (100%)
$-165.6 (-57.98%)
161
Which stock is Michael Yee is most bullish on?
Which stock is Michael Yee is most reserved on?
What Year was the first public recommendation made by Michael Yee?